IMLYGIC (talimogene laherparepvec) for Melanoma - Cancer Therapy Advisor

IMLYGIC (talimogene laherparepvec) for Melanoma

Slideshow

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

This slideshow reviews drug information for IMLYGIC (talimogene laherparepvec), indicated for melanoma.

Table of Contents

Slide 3: Indication, Dosage, and Administration
Slide 10: Use in Specific Populations
Slide 13: Clinical Pharmacology
Slide 17: Warnings and Precautions
Slide 21: Clinical Safety and Efficacy
Slide 27: Drug Storage and Supply
Slide 30: References

Next hm-slideshow in Skin Cancer